Strong Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T-Lymphocyte Activity in Sydney Blood Bank Cohort Patients Infected with nef-Defective HIV Type 1

Proposals for the use of live attenuated human immunodeficiency virus (HIV) type 1 (HIV-1) as a vaccine candidate in humans have been based on the protection afforded by attenuated simian immunodeficiency virus in the macaque model. Although it is not yet known if this strategy could succeed in huma...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Dyer, Wayne B., Ogg, Graham S., Demoitie, Marie-Ange, Jin, Xia, Geczy, Andrew F., Rowland-Jones, Sarah L., McMichael, Andrew J., Nixon, Douglas F., Sullivan, John S.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1999
Assuntos:	Pathogenesis and Immunity
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC103850/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9847349/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.73.1.436-443.1999
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!